As of Aug 18
| 0.00 / 0.00%|
The 5 analysts offering 12-month price forecasts for Antares Pharma Inc have a median target of 4.30, with a high estimate of 6.00 and a low estimate of 4.00. The median estimate represents a +40.52% increase from the last price of 3.06.
The current consensus among 5 polled investment analysts is to Buy stock in Antares Pharma Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.